Search results for " healthcare"
Article
Healthcare Reform in China
8-12
On March 25, 2014, the Chinese government announced a string of initiatives in a continued move to overhaul the healthcare system in the country. These initiatives include expansion of publi…
Resource
Medicines and Healthcare products Regulatory Agency
The Medicines and Healthcare products Regulatory Agency (MHRA) is the United Kingdom's government agency responsible for ensuring that medicines and medical devices work, and are acceptably safe. T…
Article
The Affordable Care Act's Impact on Innovation in Biopharma
…scrambling to understand how their business model, including its ability to innovate, will change as healthcare reform moves forward. Within this uncertain market, what is obvious is that the industr…
Article
Navigating Emerging Markets: Middle East and North Africa
In fact, the region known as the Middle East contains a mixture of countries with significant differences in wealth, standard of living, and healthcare system sophistication. The region, however, does…
Article
Biotechnology Innovation and Growth in Israel
The infrastructure of Israel’s healthcare system has come under scrutiny in recent years as the Israeli government continues to rein in its healthcare expenditures. Even though Israel’s economy has re…
Article
Bracing for a Future Wave of Advanced Therapies
As a result, both regulatory and industry are strengthening their relationship with the goal of preparing the US healthcare market for the entrance of these new products.
State of the industry
…
Article
The Bullish Outlook for Biosimilars
Biosimilar markets at different stages
As healthcare costs continue to rise, there is a global imperative to find cost-effective countermeasures. Despite broad recognition that biosimilars may offe…
Article
A Bright Future for the Plasma Fractionation Industry
The meeting was opened with a much appreciated keynote lecture given by Paul Perreault, CEO and managing director at CSL Ltd, on the topic “Global Healthcare Evolution and the Participation of the Ind…
Article
Biosimilars Development and Supply: How Complex Can the Process Be?
With expanding demand for good-quality healthcare comes the challenge of controlling healthcare expenditures (1). The goals behind the safe and regulated introduction of biosimilars into the market in…
Article
Drug Discovery and Development in India
Similarly, Cadila Healthcare launched Lipaglyn (saroglitazar) in June 2013, for the treatment of diabetes. Saroglitazar is claimed to be the first new chemical entity (NCE) discovered and developed by…